We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

76 hedge funds and large institutions have $236M invested in Intellia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

9% more funds holding

Funds holding: 70 → 76 (+6)

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

2% less capital invested

Capital invested by funds: $241M → $236M (-$5.18M)

4.6% less ownership

Funds ownership: 51.07% → 46.47% (-4.6%)

20% less call options, than puts

Call options by funds: $478K | Put options by funds: $599K

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
19
Reduced
18
Closed
11
Calls
$478K
Puts
$599K
Net Calls
-$121K
Net Calls Change
-$121K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.7M
2
GC
GMT Capital
Georgia
+$4.44M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.29M
4
PC
Paulson & Co
New York
+$1.05M
5
AIM
ARK Investment Management
Florida
+$715K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.3M
2
AVAI
Atlas Venture Associates IX
Massachusetts
-$9.39M
3
FCMI
Foresite Capital Management III
California
-$7.43M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.83M
5
Millennium Management
Millennium Management
New York
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$446K +$22.6K +1,682 +6%
AL
27
Airain Ltd
Guernsey
$381K +$363K +27,050 New
Charles Schwab
28
Charles Schwab
California
$380K +$20.7K +1,539 +6%
Millennium Management
29
Millennium Management
New York
$365K -$1.78M -132,670 -84%
AllianceBernstein
30
AllianceBernstein
Tennessee
$364K – – –
Swiss National Bank
31
Swiss National Bank
Switzerland
$292K – – –
ProShare Advisors
32
ProShare Advisors
Maryland
$282K -$65.6K -4,886 -20%
TCIM
33
TIAA CREF Investment Management
New York
$276K -$78.2K -5,825 -23%
Barclays
34
Barclays
United Kingdom
$267K +$103K +7,659 +68%
ZIM
35
Zacks Investment Management
Illinois
$254K +$242K +18,002 New
Bank of America
36
Bank of America
North Carolina
$251K +$195K +14,558 +444%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$198K -$4.03K -300 -2%
M&T Bank
38
M&T Bank
New York
$162K +$155K +11,516 New
TA
39
Teachers Advisors
New York
$156K +$1.19K +89 +0.8%
Wells Fargo
40
Wells Fargo
California
$154K +$103K +7,645 +232%
HCM
41
Highbridge Capital Management
New York
$149K +$142K +10,552 New
ARTA
42
A.R.T. Advisors
New York
$148K +$141K +10,541 New
Commonwealth Equity Services
43
Commonwealth Equity Services
Massachusetts
$147K -$4.7K -350 -3%
MF
44
Magnetar Financial
Illinois
$142K +$135K +10,081 New
MIC
45
Meridian Investment Counsel
California
$141K +$134K +10,000 New
Russell Investments Group
46
Russell Investments Group
United Kingdom
$137K +$130K +9,698 New
Group One Trading
47
Group One Trading
Illinois
$123K +$117K +8,700 New
IWM
48
IHT Wealth Management
Illinois
$117K +$111K +8,280 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$101K +$13 +1 +0%
CAM
50
ClariVest Asset Management
California
$90K -$35.8K -2,665 -29%
1
2
3 4

NTLA Hedge Fund Activity: Q1 2017 in Review

76 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q1 2017, worth a combined $236M — down 2.2% from $241M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new NTLA positions and 11 closed out — a net gain of 12 holders — while 19 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $12.7M. The largest seller was Fidelity Investments, cutting an estimated $10.3M.

  • 76 institutional investors held Intellia Therapeutics (NTLA) as of Q1 2017, up from 70 in Q4 2016.
  • Funds reported $236M of Intellia Therapeutics stock for Q1 2017, down 2.2% quarter-over-quarter.
  • 23 funds opened new Intellia Therapeutics positions in Q1 2017 and 11 closed out, a net change of +12 holders.
  • The largest Intellia Therapeutics buyer in Q1 2017 was BlackRock, an estimated $12.7M added.
  • The largest Intellia Therapeutics seller in Q1 2017 was Fidelity Investments, an estimated $10.3M sold.

Based on aggregated 13F filings for Q1 2017.